The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
A Review of Neuroprotection Pharmacology and Therapies in Patients with Acute Traumatic Brain Injury
Abstract
Traumatic brain injury (TBI) affects 1.6 million Americans annually. The injury severity impacts the overall outcome and likelihood for survival. Current treatment of acute TBI includes surgical intervention and supportive care therapies. Treatment of elevated intracranial pressure and optimizing cerebral perfusion are cornerstones of current therapy. These approaches do not directly address the secondary neurological sequelae that lead to continued brain injury after TBI. Depending on injury severity, a complex cascade of processes are activated and generate continued endogenous changes affecting cellular systems and overall outcome from the initial insult to the brain. Homeostatic cellular processes governing calcium influx, mitochondrial function, membrane stability, redox balance, blood flow and cytoskeletal structure often become dysfunctional after TBI. Interruption of this cascade has been the target of numerous pharmacotherapeutic agents investigated over the last two decades. Many agents such as selfotel, pegorgotein (PEG-SOD), magnesium, deltibant and dexanabinol were ineffective in clinical trials. While progesterone and ciclosporin have shown promise in phase II studies, success in larger phase III, randomized, multicentre, clinical trials is pending. Consequently, no neuroprotective treatment options currently exist that improve neurological outcome after TBI. Investigations to date have extended understanding of the injury mechanisms and sites for intervention.…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, no effective interventions are available to improve recovery following TBI (42–44).”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [42]
Citations
Cites
A controlled cortical impact model of traumatic brain injury in the rat
Edward Dixon, C., Clifton, G. L., Lighthall, J. W., Yaghmai, A. A., & Hayes, R. L. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90104-8 · Cited by 1,141
Clinical trials in head injury
Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., et al. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754037 · Cited by 913
Antioxidant Therapies for Traumatic Brain Injury
Hall, E. D., Vaishnav, R. A., & Mustafa, A. G. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2009.10.021 · Cited by 390 · cited 1×
“These reactive species may overwhelm endogenous antioxidant stores, such as superoxide dismutase (SOD), causing DNA damage and lipid peroxidation, which can propagate well beyond the site of origin.([38,39]) The inflammatory response to TBI, like inmany other types of critical illness, can either be harmful or helpful…”
BackgroundÅberg, N. D., Brywe, K. G., & Isgaard, J. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.22 · Cited by 387
Experimental models of traumatic brain injury: do we really need to build a better mousetrap?
Morales, D. M., Marklund, N., Lebold, D., Thompson, H. J., Pitkanen, A., Maxwell, W. L., Longhi, L., Laurer, H., Maegele, M., Neugebauer, E., et al. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.030 · Cited by 339 · cited 1×
“However, the heterogeneity of TBI in reality is difficult to replicate.([71]) Patients often present with more than one abnormality or injury type due to neurotrauma.”
BackgroundOertel, M., Boscardin, W. J., Obrist, W. D., Glenn, T. C., McArthur, D. L., Gravori, T., Lee, J. H., & Martin, N. A. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.103.5.0812 · Cited by 227
Ropper, A. H., & Gorson, K. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp064645 · Cited by 215
Saatman, K. E., Contreras, P. C., Smith, D. H., Raghupathi, R., McDermott, K. L., Fernandez, S. C., Sanderson, K. L., Voddi, M., & McIntosh, T. K. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6629 · Cited by 185
Research works printed but not linked: 203
- Thurman, 1999 Sep 8, JAMA, 282, 954, 10.1001/jama.282.10.954 · DOI
- Thurman, 1999 Dec, J Head Trauma Rehabil, 14, 602, 10.1097/00001199-199912000-00009 · DOI
- Coronado, 2011 May 6, MMWR Surveill Summ, 60, 1
- Roozenbeek, 2012, J Neurotrauma, 29, 1306, 10.1089/neu.2011.1988 · DOI
- Clifton, 2011 Feb, Lancet Neurol, 10, 131, 10.1016/S1474-4422(10)70300-8 · DOI
- Patel, 2005 Oct 29-Nov 4, Lancet, 366, 1538, 10.1016/S0140-6736(05)67626-X · DOI
- Marshall, 1991, J Neurosurg, 75, S28, 10.3171/sup.1991.75.1s.0s28 · DOI
- Roberts, 2004 Oct 9-15, Lancet, 364, 1321, 10.1016/S0140-6736(04)17188-2 · DOI · Paper page
- De Kruijk, 2002 Dec, J Neurol Neurosurg Psychiatr, 73, 727, 10.1136/jnnp.73.6.727 · DOI
- Ryan, 2003 Nov, Int Rev Psychiatry, 15, 310, 10.1080/09540260310001606692 · DOI
- Ling, 2009 Jun, J Neurotrauma, 26, 815, 10.1089/neu.2007.0484 · DOI
- Sahuquillo, 2001, Curr Pharm Des, 7, 1475, 10.2174/1381612013397311 · DOI
- Andriessen, 2010 Oct, J Cell Mol Med, 14, 2381, 10.1111/j.1582-4934.2010.01164.x · DOI
- 2007, J Neurotrauma, 24, S1, 10.1089/neu.2007.9997 · DOI
- Rhoney, 2006, Nutr Clin Pract, 21, 462, 10.1177/0115426506021005462 · DOI
- Clifton, 2002, Crit Care Med, 30, 739, 10.1097/00003246-200204000-00003 · DOI
- Hatton, 2001, CNS Drugs, 15, 553, 10.2165/00023210-200115070-00005 · DOI
- Werner, 2007 Jul, Br J Anaesth, 99, 4, 10.1093/bja/aem131 · DOI · Paper page
- Enriquez, 2004, Curr Pharm Des, 10, 2131, 10.2174/1381612043384060 · DOI
- Czosnyka, 2001 Nov, J Neurosurg, 95, 756, 10.3171/jns.2001.95.5.0756 · DOI
- Manley, 2001 Oct, Arch Surg, 136, 1118, 10.1001/archsurg.136.10.1118 · DOI
- DeWitt, 2003 Sep, J Neurotrauma, 20, 795, 10.1089/089771503322385755 · DOI · Paper page
- Steiner, 2003 Oct, Stroke, 34, 2404, 10.1161/01.STR.0000089014.59668.04 · DOI
- Cherian, 2004 Apr, Brain Pathol, 14, 195, 10.1111/j.1750-3639.2004.tb00053.x · DOI
- Schroder, 1998, Acta Neurochir Suppl, 71, 127
- Schroder, 1996 Jan, J Neurotrauma, 13, 17, 10.1089/neu.1996.13.17 · DOI
- Obrist, 1984 Aug, J Neurosurg, 61, 241, 10.3171/jns.1984.61.2.0241 · DOI
- Overgaard, 1974 Nov, J Neurosurg, 41, 531, 10.3171/jns.1974.41.5.0531 · DOI
- Martin, 1997 Jul, J Neurosurg, 87, 9, 10.3171/jns.1997.87.1.0009 · DOI
- Langham, 2003, Cochrane Database Syst Rev, 4, CD000565
- Hall, 1993 Feb, J Neurochem, 60, 588, 10.1111/j.1471-4159.1993.tb03189.x · DOI
- Shohami, 1997 Oct, J Cerebral Blood Flow Metab, 17, 1007, 10.1097/00004647-199710000-00002 · DOI
- Lewen, 2000 Oct, J Neurotrauma, 17, 871, 10.1089/neu.2000.17.871 · DOI · Paper page
- Ray, 2002 Oct, Histol Histopathol, 17, 1137
- Lenzlinger, 2001 Aug-Dec, Mol Neurobiol, 24, 169, 10.1385/MN:24:1-3:169 · DOI · Paper page
- Yang, 2007 Sep, Neurosci Bull, 23, 307, 10.1007/s12264-007-0046-6 · DOI
- Ott, 1994, J Neurotrauma, 11, 447, 10.1089/neu.1994.11.447 · DOI
- Royo, 1999 Apr 26, Neuroreport, 10, 1363, 10.1097/00001756-199904260-00038 · DOI
- Stahel, 1998 Aug, Brain Res Brain Res Rev, 27, 243, 10.1016/S0165-0173(98)00015-0 · DOI
- Baldwin, 1996 Sep, J Neurosurg, 85, 476, 10.3171/jns.1996.85.3.0476 · DOI
- Marmarou, 2007, Neurosurg Focus, 22, 1, 10.3171/foc.2007.22.5.2 · DOI
- Venero, 2004, Curr Pharm Des, 10, 2153, 10.2174/1381612043384150 · DOI
- Young, 1992 Mar, J Neurotrauma, 9, S9
- Kawamata, 1995 Mar 20, Brain Res, 674, 196, 10.1016/0006-8993(94)01444-M · DOI
- Mazzeo, 2009 Aug, Exp Neurol, 218, 363, 10.1016/j.expneurol.2009.05.026 · DOI
- Sullivan, 2005, J Neurosci Res, 79, 231, 10.1002/jnr.20292 · DOI
- Kampfl, 1997 Mar, J Neurotrauma, 14, 121, 10.1089/neu.1997.14.121 · DOI
- Raghupathi, 2004 Apr, Brain Pathol, 14, 215, 10.1111/j.1750-3639.2004.tb00056.x · DOI
- Sarnaik, 2010 Mar, J Neurotrauma, 27, 465, 10.1089/neu.2009.1171 · DOI
- Hatton, 2006 Dec, J Neurosurg, 105, 843, 10.3171/jns.2006.105.6.843 · DOI · Paper page
- Neff, 1993 Dec, J Neurobiol, 24, 1578, 10.1002/neu.480241203 · DOI
- Saenger, 2011 Oct, Growth Horm IGF Res, 21, 292, 10.1016/j.ghir.2011.07.006 · DOI
- Taguchi, 2008, Annu Rev Physiol, 70, 191, 10.1146/annurev.physiol.70.113006.100533 · DOI
- Zeger, 2007 Mar, Glia, 55, 400, 10.1002/glia.20469 · DOI
- Kazanis, 2004 Apr, Exp Neurol, 186, 221, 10.1016/j.expneurol.2003.12.004 · DOI
- Rockich, 1999, Pharmacotherapy, 19, 1432, 10.1592/phco.19.18.1432.30891 · DOI
- Metzger, 2011 Jun 3, J Biol Chem, 286, 19501, 10.1074/jbc.M110.172189 · DOI
- Xi, 2002, Neurosurg Clin N Am, 13, 371, 10.1016/S1042-3680(02)00007-4 · DOI
- Schouten, 2007, Curr Opin Crit Care, 13, 134, 10.1097/MCC.0b013e3280895d5c · DOI · Paper page
- Bullock, 1999, Neurosurgery, 45, 207, 10.1097/00006123-199908000-00001 · DOI
- Tolias, 2004, NeuroRx, 1, 71, 10.1602/neurorx.1.1.71 · DOI
- Sullivan, 2000, Neuroscience, 101, 289, 10.1016/S0306-4522(00)00380-8 · DOI
- Lee, 2001, Pharmacol Rev, 53, 569, 10.1146/annurev.pharmtox.41.1.569 · DOI
- Loscher, 2005, Nature Rev Neurosci, 6, 591, 10.1038/nrn1728 · DOI
- Boucher, 1998, Clin Pharmacokinet, 35, 209, 10.2165/00003088-199835030-00004 · DOI
- McKindley, 1997, J Clin Pharmacol, 37, 129, 10.1002/j.1552-4604.1997.tb04771.x · DOI
- Baraldo, 1999, Pharmacol Res, 40, 483, 10.1006/phrs.1999.0539 · DOI
- Kovarik, 1999, Drugs Aging, 15, 197, 10.2165/00002512-199915030-00003 · DOI
- Ptachcinski, 1985, Clin Pharmacol Ther, 38, 296, 10.1038/clpt.1985.174 · DOI
- Cook, 2009, Expert Opin Drug Saf, 8, 411, 10.1517/14740330903066742 · DOI
- Empey, 2006, J Neurotrauma, 23, 109, 10.1089/neu.2006.23.109 · DOI · Paper page
- Temkin, 2007, Lancet Neurol, 6, 29, 10.1016/S1474-4422(06)70630-5 · DOI
- Wright, 2007, Ann Emerg Med, 49, 391, 10.1016/j.annemergmed.2006.07.932 · DOI
- Guilfoyle, 2010 Dec, J Neurotrauma, 27, 2173, 10.1089/neu.2010.1353 · DOI
- von Steinbuchel, 2010 Jul, J Neurotrauma, 27, 1157, 10.1089/neu.2009.1077 · DOI
- Pineda, 2007 Feb, J Neurotrauma, 24, 354, 10.1089/neu.2006.003789 · DOI
- Manley, 2010 Nov, Arch Phys Med Rehabil, 91, 1667, 10.1016/j.apmr.2010.05.018 · DOI
- Ottens, 2010 Oct, J Neurotrauma, 27, 1837, 10.1089/neu.2010.1374 · DOI
- Kochanek, 2008 Apr, Curr Opin Crit Care, 14, 135, 10.1097/MCC.0b013e3282f57564 · DOI
- Maas, 2006, Lancet Neurol, 5, 38, 10.1016/S1474-4422(05)70253-2 · DOI
- Marmarou, 2005 Dec, J Neurotrauma, 22, 1444, 10.1089/neu.2005.22.1444 · DOI
- Hatton, 2008, J Neurosurg, 109, 699, 10.3171/JNS/2008/109/10/0699 · DOI
- Marmarou, 1999 Jun, J Neurotrauma, 16, 431, 10.1089/neu.1999.16.431 · DOI
- Young, 1996 Aug, JAMA, 276, 538, 10.1001/jama.1996.03540070034027 · DOI
- Muizelaar, 1993, J Neurosurg, 78, 375, 10.3171/jns.1993.78.3.0375 · DOI
- Xiao, 2008, Crit Care, 12, R61, 10.1186/cc6887 · DOI
- Merchant, 1999, Ann N Y Acad Sci, 890, 42, 10.1111/j.1749-6632.1999.tb07979.x · DOI
- Yurkewicz, 2005 Dec, J Neurotrauma, 22, 1428, 10.1089/neu.2005.22.1428 · DOI
- Maas, 2006 Jan, Lancet Neurol, 5, 38, 10.1016/S1474-4422(05)70253-2 · DOI
- Natale, 2007, Pediatr Crit Care Med, 8, 1, 10.1097/01.pcc.0000256620.55512.5f · DOI
- Bailey, 1991, Acta Neurochir (Wien), 110, 97, 10.1007/BF01400674 · DOI
- Teasdale, 1992, J Neurotruama, 9, S545
- Murray, 1996, Acta Neurochir (Wien), 138, 1163, 10.1007/BF01809745 · DOI
- 1994, J Neurosurg, 80, 797, 10.3171/jns.1994.80.5.0797 · DOI
- Pillai, 2003, Neurol India, 51, 361
- Zhou, 2002, Di Yi Jun Yi Da Xue Xue Bao, 22, 527
- Tapia-Perez, 2008, J Neurotrauma, 25, 1011, 10.1089/neu.2008.0554 · DOI
- Morris, 1999, J Neurosurg, 91, 737, 10.3171/jns.1999.91.5.0737 · DOI
- Marshall, 1998, J Neurosurg, 89, 519, 10.3171/jns.1998.89.4.0519 · DOI
- LaPlaca, 2001, J Neurotrauma, 18, 369, 10.1089/089771501750170912 · DOI
- Hoane, 2008, Oxid Med Cell Longev, 1, 46, 10.4161/oxim.1.1.6694 · DOI
- Goffus, 2010, Oxid Med Cell Longev, 3, 145, 10.4161/oxim.3.2.11315 · DOI
- Swan, 2011, J Neurotrauma, 28, 431, 10.1089/neu.2010.1519 · DOI
- Hoane, 2006, J Neurotrauma, 23, 1535, 10.1089/neu.2006.23.1535 · DOI
- Holland, 2008, J Neurotruama, 25, 140, 10.1089/neu.2007.0312 · DOI
- Hoane, 2008, Neuroscience, 154, 861, 10.1016/j.neuroscience.2008.04.044 · DOI
- Abdel Baki, 2010, PLoS ONE, 5, e12490, 10.1371/journal.pone.0012490 · DOI
- Chen, 2008, Mediators Inflamm, 2008, 716458, 10.1155/2008/716458 · DOI
- Khan, 2011 July 6, J Neuroinflammation, 8, 78, 10.1186/1742-2094-8-78 · DOI
- Khan, 2009 Nov 4, J Neuroinflammation, 6, 32, 10.1186/1742-2094-6-32 · DOI
- Qu, 2010, J Neurotrauma, 27, 1625, 10.1089/neu.2010.1359 · DOI
- Arun, 2010, J Neurotruama, 27, 293, 10.1089/neu.2009.0994 · DOI
- Appelberg, 2009, J Neurotrauma, 26, 497, 10.1089/neu.2008.0664 · DOI
- Pike, 1995, Brain Res, 686, 37, 10.1016/0006-8993(95)00448-Y · DOI
- Durmaz, 2003 Nov 15, J Neurol Sci, 215, 87, 10.1016/S0022-510X(03)00207-7 · DOI
- Durmaz, 2003 May, Can J Neurol Sci, 30, 143, 10.1017/S0317167100053415 · DOI
- Lu, 2009, J Neurotrauma, 26, 141, 10.1089/neu.2008.0629 · DOI
- Wei, 2009 August 7, J Neuroinflammation, 6, 19, 10.1186/1742-2094-6-19 · DOI
- Berman, 2000, J Neurosurg, 93, 821, 10.3171/jns.2000.93.5.0821 · DOI
- Verweij, 2000, J Neurosurg, 93, 829, 10.3171/jns.2000.93.5.0829 · DOI
- Faden, 2001, Exp Neurol, 167, 435, 10.1006/exnr.2000.7577 · DOI
- Movsesyan, 2001, J Pharmacol Exp Ther, 296, 41
- Barbre, 2006, Brain Res Bull, 69, 639, 10.1016/j.brainresbull.2006.03.009 · DOI
- Hoane, 2005, J Neurotrauma, 22, 1112, 10.1089/neu.2005.22.1112 · DOI
- Belayev, 2002, J Neurosurg, 96, 1077, 10.3171/jns.2002.96.6.1077 · DOI
- Guluma, 1999, J Neurotrauma, 16, 311, 10.1089/neu.1999.16.311 · DOI
- Dietrich, 1996, J Neurotrauma, 13, 309, 10.1089/neu.1996.13.309 · DOI
- McDermott, 1997, J Neurotrauma, 14, 191, 10.1089/neu.1997.14.191 · DOI
- Sun, 2009, Exp Neurol, 216, 56, 10.1016/j.expneurol.2008.11.011 · DOI
- Cernak, 2002, Exp Brain Res, 147, 193, 10.1007/s00221-002-1245-z · DOI
- Wahl, 2000 Nov, J Neurotrauma, 17, 1055, 10.1089/neu.2000.17.1055 · DOI
- Stutzmann, 2002 Spring, CNS Drug Rev, 8, 1, 10.1111/j.1527-3458.2002.tb00213.x · DOI
- Bye, 2007 Mar, Exp Neurol, 204, 220, 10.1016/j.expneurol.2006.10.013 · DOI
- Crack, 2009 Jan, J Neural Transm, 116, 1, 10.1007/s00702-008-0145-1 · DOI
- Homsi, 2009 Sep 29, Brain Res, 1291, 122, 10.1016/j.brainres.2009.07.031 · DOI
- Homsi, 2010 May, J Neurotrauma, 27, 911, 10.1089/neu.2009.1223 · DOI
- Stover, 2000, J Neurotrauma, 17, 1171, 10.1089/neu.2000.17.1171 · DOI
- Zhang, 1998, J Neurosci Res, 52, 342, 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8 · DOI
- Zhang, 2009, Brain Res, 1294, 153, 10.1016/j.brainres.2009.07.077 · DOI
- Zhang, 2010, Brain Res, 1353, 249, 10.1016/j.brainres.2010.07.046 · DOI
- Liao, 2008, Eur J Neurol, 15, 140, 10.1111/j.1468-1331.2007.02013.x · DOI
- Zhao, 2011, Cytokine, 56, 343, 10.1016/j.cyto.2011.07.018 · DOI
- Hartley, 2008, J Neurosurg, 109, 708, 10.3171/JNS/2008/109/10/0708 · DOI
- Grasso, 2007, Brain Res, 1182, 99, 10.1016/j.brainres.2007.08.078 · DOI
- Chen, 2007, Neurosci Lett, 425, 177, 10.1016/j.neulet.2007.08.022 · DOI
- Liao, 2009, Neurol India, 57, 722, 10.4103/0028-3886.59466 · DOI
- Mammis, 2009, Surg Neurol, 71, 527, 10.1016/j.surneu.2008.02.040 · DOI
- Xiong, 2011, J Neurosurg, 114, 549, 10.3171/2010.10.JNS10925 · DOI
- Xiong, 2010, J Neurosurg, 113, 598, 10.3171/2009.9.JNS09844 · DOI
- Brines, 2000, Proc Natl Acad Sci USA, 97, 10526, 10.1073/pnas.97.19.10526 · DOI
- Kuypers, 2010, J Neurotrauma, 27, 1275, 10.1089/neu.2010.1327 · DOI
- Kleindienst, 2004, J Neurotrauma, 21, 541, 10.1089/089771504774129874 · DOI
- Kleindienst, 2005, J Neurotruama, 22, 645, 10.1089/neu.2005.22.645 · DOI
- Kline, 2002, J Neurotrauma, 19, 415, 10.1089/08977150252932370 · DOI
- Mauler, 2003, Brain Res, 989, 99, 10.1016/S0006-8993(03)03376-6 · DOI
- Mauler, 2003, CNS Drug Rev, 9, 343, 10.1111/j.1527-3458.2003.tb00259.x · DOI
- Mesenge, 1996, J Neurotrauma, 13, 11, 10.1089/neu.1996.13.11 · DOI
- Hogg, 1998, Behav Brain Res, 93, 157, 10.1016/S0166-4328(97)00145-9 · DOI
- Bernert, 1996, Proc Natl Acad Sci USA, 93, 5235, 10.1073/pnas.93.11.5235 · DOI
- Ikonomidou, 1996, Metab Brain Dis, 11, 125, 10.1007/BF02069500 · DOI
- Pohl, 1999, Proc Natl Acad Sci USA, 96, 2508, 10.1073/pnas.96.5.2508 · DOI
- McIntosh, 1999, J Neurochem, 55, 1170, 10.1111/j.1471-4159.1990.tb03122.x · DOI
- Okiyama, 1998, Brain Res, 792, 291, 10.1016/S0006-8993(98)00158-9 · DOI
- Kroppenstedt, 1998, J Neurotrauma, 15, 191, 10.1089/neu.1998.15.191 · DOI
- Toulmond, 1993, Brain Res, 620, 32, 10.1016/0006-8993(93)90267-Q · DOI
- Hogg, 1998, J Neurotrauma, 15, 545, 10.1089/neu.1998.15.545 · DOI
- Mueller, 2000, Amino Acids, 19, 177, 10.1007/s007260070047 · DOI
- Dohi, 2006, J Neurotrauma, 23, 1591, 10.1089/neu.2006.23.1591 · DOI
- Itoh, 2010, Neurochem Res, 35, 348, 10.1007/s11064-009-0061-2 · DOI
- Wang, 2011, J Neurotrauma, 28, 2123, 10.1089/neu.2011.1939 · DOI
- Belayev, 2001, J Neurotrauma, 18, 1031, 10.1089/08977150152693728 · DOI
- Kline, 2001, Neuroscience, 106, 547, 10.1016/S0306-4522(01)00300-1 · DOI
- Mauler, 2005, J Cereb Blood Flow Metab, 25, 451, 10.1038/sj.jcbfm.9600038 · DOI
- Cheng, 2007, Neurosci Lett, 416, 165, 10.1016/j.neulet.2007.02.006 · DOI
- Cheng, 2008, Behav Brain Res, 194, 79, 10.1016/j.bbr.2008.06.025 · DOI
- Kline, 2007, Behav Brain Res, 177, 186, 10.1016/j.bbr.2006.11.036 · DOI
- Kline, 2004, J Neurotrauma, 21, 175, 10.1089/089771504322778631 · DOI
- Kline, 2010, J Neurotruama, 27, 2021, 10.1089/neu.2010.1535 · DOI
- Kline, 2002, Neurosci Lett, 333, 179, 10.1016/S0304-3940(02)01101-1 · DOI
- Ma, 2011, Mol Med Rep, 4, 849
- Wallenquist, 2009, Restor Neurol Neurosci, 2009, 323
- Harting, 2009, J Surg Res, 153, 188, 10.1016/j.jss.2008.03.037 · DOI
- Shohami, 1996, J Cereb Blood Flow Metab, 16, 378, 10.1097/00004647-199605000-00004 · DOI
- Chio, 2010, J Neurochem, 115, 921, 10.1111/j.1471-4159.2010.06969.x · DOI
- Kinoshita, 2002, J Neurotrauma, 19, 681, 10.1089/08977150260139075 · DOI
- Liu-DeRyke, 2009, Neurocrit Care, 11, 151, 10.1007/s12028-009-9228-6 · DOI
- Rovlias, 2000, Neurosurgery, 46, 342, 10.1097/00006123-200002000-00015 · DOI
- Salim, 2009, Am Surg, 75, 25, 10.1177/000313480907500105 · DOI
- Diaz-Parejo, 2003, Intensive Care Med, 29, 544, 10.1007/s00134-003-1669-3 · DOI
- Alderson, 2005 Jan 25, Cochrane Database Syst Rev, 1, CD000196
- Mazzeo, 2008, Acta Neurochir (Wien), 150, 1019, 10.1007/s00701-008-0021-7 · DOI
- Mazzeo, 2009 Dec, J Neurotrauma, 26, 2195, 10.1089/neu.2009.1012 · DOI
- Knoller, 2002, Crit Care Med, 30, 548, 10.1097/00003246-200203000-00009 · DOI
- McIntosh, 1988, J Neurotrauma, 5, 17, 10.1089/neu.1988.5.17 · DOI
- Lee, 2004, J Neurotrauma, 21, 549, 10.1089/089771504774129883 · DOI
- Hoane, 2005, Restor Neurol Neurosci, 23, 67
- Wagstaff, 1995 Sep 15, Ann N Y Acad Sci, 15, 332, 10.1111/j.1749-6632.1995.tb16607.x · DOI
- Bullock, 1999, Ann N Y Acad Sci, 51-, 8
- Stein, 2008, Brain Res Rev, 57, 386, 10.1016/j.brainresrev.2007.06.012 · DOI
- Weant, 2007, Pharmacotherapy, 27, 1279, 10.1592/phco.27.9.1279 · DOI
200 of 203 shown
Cited by
Sorted by citations
Inflammation and neuroprotection in traumatic brain injury.
Corps, K. N., Roth, T. L., & McGavern, D. B. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3558 · Cited by 853
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Jassam, Y. N., Izzy, S., Whalen, M., McGavern, D. B., & El Khoury, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.010 · Cited by 799
Zhang, Y., Chopp, M., Meng, Y., Katakowski, M., Xin, H., Mahmood, A., & Xiong, Y. (2015) · Journal of neurosurgery · doi:10.3171/2014.11.jns14770 · Cited by 737
Transcranial amelioration of inflammation and cell death after brain injury.
Roth, T. L., Nayak, D., Atanasijevic, T., Koretsky, A. P., Latour, L. L., & McGavern, D. B. (2014) · Nature · doi:10.1038/nature12808 · Cited by 574
“moderate, and severe forms of injury 5 , but therapeutic research in these models has not yet translated successfully into the clinic 4, 13 .”
Bramlett, H. M., & Dietrich, W. D. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2014.3352 · Cited by 590
“258 However, lessons have been learned and strategies proposed on how best to approach the translation of pre-clinical data to the clinic.”
Metadata
- Authors
- McConeghy, K. W., Hatton, J., Hughes, L., & Cook, A. M.
- Affiliations
- University of Kentucky HealthCare (US)
- University of Kentucky (US)
- Corresponding author
- Cook, Aaron M.
- Venue
- CNS Drugs
- Published
- 2012-07
- Volume
- 26
- Issue
- 7
- Pages
- 613-636
- ISSN
- 1172-7047 (ISSN-L)
- OpenAlex
- W2006925820
- Cited by
- 158
- References
- 0
- Citations by year
- 2025: 4 · 2024: 8 · 2023: 3 · 2022: 10 · 2021: 8 · 2020: 10 · 2019: 11 · 2018: 16 · 2017: 20 · 2016: 17 · 2015: 18 · 2014: 17 · 2013: 13 · 2012: 3
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- traumatic brain injury, neuroprotection, secondary brain injury, intracranial pressure, cerebral perfusion, calcium influx, mitochondrial dysfunction, redox homeostasis, blood flow, cytoskeleton, magnesium, progesterone, cyclosporine, biomarkers, clinical trial design
- MeSH terms
- Animals, Brain Injuries, Clinical Trials as Topic, Humans, Prognosis, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review